| Literature DB >> 28579835 |
Bevin Cohen1, Catherine Crawford Cohen1, Borghild Løyland2, Elaine L Larson1.
Abstract
Pathogens that cause health care-associated infections (HAIs) are known to survive on surfaces and equipment in health care environments despite routine cleaning. As a result, the infection status of prior room occupants and roommates may play a role in HAI transmission. We performed a systematic review of the literature evaluating the association between patients' exposure to infected/colonized hospital roommates or prior room occupants and their risk of infection/colonization with the same organism. A PubMed search for English articles published in 1990-2014 yielded 330 studies, which were screened by three reviewers. Eighteen articles met our inclusion criteria. Multiple studies reported positive associations between infection and exposure to roommates with influenza and group A streptococcus, but no associations were found for Clostridium difficile, methicillin-resistant Staphylococcus aureus, Cryptosporidium parvum, or Pseudomonas cepacia; findings were mixed for vancomycin-resistant enterococci (VRE). Positive associations were found between infection/colonization and exposure to rooms previously occupied by patients with Pseudomonas aeruginosa and Acinetobacter baumannii, but no associations were found for resistant Gram-negative organisms; findings were mixed for C. difficile, methicillin-resistant S. aureus, and VRE. Although the majority of studies suggest a link between exposure to infected/colonized roommates and prior room occupants, methodological improvements such as increasing the statistical power and conducting universal screening for colonization would provide more definitive evidence needed to establish causality.Entities:
Keywords: health care-associated infections; hospital roommates; multidrug-resistant organisms; prior room occupants
Year: 2017 PMID: 28579835 PMCID: PMC5448698 DOI: 10.2147/CLEP.S124382
Source DB: PubMed Journal: Clin Epidemiol ISSN: 1179-1349 Impact factor: 4.790
Assessment of study quality
| Quality measure | Yes (%) | No (%) | Cannot determine | Not applicable |
|---|---|---|---|---|
| 18 (100) | 0 | 0 | 0 | |
| Population, intervention or exposure, and outcome included? Yes=1; No=0 | ||||
| Note: Score may be based on study’s main aim | ||||
| 17 (94) | 1 (6) | 0 | 0 | |
| Enough information provided to replicate study? Yes=1; No=0 | ||||
| 18 (100) | 0 | 0 | 0 | |
| General patient population and inclusion/exclusion criteria described? Yes=1; No=0 | ||||
| Note: Descriptive statistics not required | ||||
| 15 (83) | 3 (17) | 0 | 0 | |
| Enough information provided to replicate study? Yes=1; No=0 | ||||
| Note: Score based on exposure of interest (ie, prior room occupant and/or roommate infection status) | ||||
| Most described: 13 (72) | 0 | 0 | 0 | |
| Most clinically relevant characteristics described=2; only a few general patient characteristics described=1; no characteristics described=0 | Few described: 3 (17) | |||
| 18 (100) | 0 | 0 | 0 | |
| Results presented for all proposed analyses and outcome measures? Yes=1; No=0 | ||||
| 18 (100) | 0 | 0 | 0 | |
| Confidence intervals, | ||||
| Note: Score based on analyses for roommate and/or prior room occupant exposures | ||||
| 2 (11) | 0 | 0 | 16 (89%) | |
| If loss to follow-up is implied, are patients described or compared to those who participated? Yes=1; No=0 | ||||
| Note: If loss to follow-up not mentioned by authors, item scored as “not applicable” and removed from denominator | ||||
| 18 (100) | 0 | 0 | 0 | |
| Yes=1; No=0 | ||||
| 16 (89) | 0 | 2 (11%) | 0 | |
| All patients identified in the source population included=1; certain patients included in the source population systematically excluded (eg, patients who died, were transferred, refused participation, etc)=0 | ||||
| Note: Zero was scored if authors did not provide enough information to determine representativeness | ||||
| 17 (94) | 0 | 1 (6%) | 0 | |
| Yes=1; No=0 | ||||
| Note: Zero was scored if authors did not provide enough information to determine representativeness | ||||
| 0 | 0 | 2 (11%) | 16 (89%) | |
| All subgroup analyses described in methods section or noted as post hoc analyses=1; unplanned subgroup analyses presented and not noted as post hoc=0 | ||||
| Note: If study included no subgroup analyses, item scored as “not applicable” and removed from denominator | ||||
| 8 (44) | 6 (33) | 0 | 4 (22%) | |
| If follow-up is differential between groups, was this controlled for in the design or analysis? Yes=1; No=0 | ||||
| Note: If follow-up is same for all patients, item scored as “not applicable” and removed from denominator | ||||
| 15 (83) | 3 (17) | 0 | 0 | |
| Statistical tests minimally appropriate for the data and research questions? Yes=1; No=0 | ||||
| 16 (89) | 1 (6) | 0 | 1 (6%) | |
| Systematic, repeatable methods of case finding and appropriate lab definitions used? Yes=1; No=0 | ||||
| Note: Zero was scored if authors did not provide enough information to assess outcome measures | ||||
| 18 (100) | 0 | 0 | 0 | |
| Yes=1; No=0 | ||||
| 18 (100) | 0 | 0 | 0 | |
| Yes=1; No=0 | ||||
| 9 (50) | 6 (33) | 3 (17%) | 0 | |
| Key confounders included in multivariable models? Yes=1; No=0 | ||||
| Note: Score based on exposure of interest (ie, prior room occupant and/or roommate infection status) | ||||
| 1 (6) | 1 (6) | 16 (89%) | 0 | |
| If loss to follow-up is reported, is an appropriate statistical method used to account for this? Yes=1; No=0 | ||||
| Note: If no loss to follow-up is reported, item scored as “not applicable” and removed from denominator. Zero was scored if authors did not provide enough information to assess loss to follow-up | ||||
| 0 | 4 (22) | 14 (78%) | 0 | |
| Power calculation included and adequate power reported=1; power calculation included and inadequate power reported or no power calculation mentioned=0 | ||||
| Note: Score based on exposure of interest (ie, prior room occupant and/or roommate infection status). Zero was scored if authors did not provide enough information to assess power |
Note:
Data collection tool from Downs and Black.24
Figure 1Identification, screening, eligibility, and inclusion of articles according to the PRISMA guidelines.
Notes: Three hundred and thirty articles were identified by database search and no additional records were identified from other sources. No duplicates were identified.
Abbreviation: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Summary and quality assessment of studies reporting associations between health care-associated infection and exposure to infected or colonized roommates
| Author, quality score | Study period | Setting | Design | Subjects | N | Outcome | Exposure | Analysis | Results |
|---|---|---|---|---|---|---|---|---|---|
| Auerbach et al | August 1989–February 1990 | 50-bed nursing home, North Carolina | Outbreak investigation and case–control | All residents who underwent diagnostic testing for GAS, excluding those who died from causes other than GAS | 37 roommate pairs | Symptomatic or asymptomatic GAS infection detected by culture or serology | Roommate w/symptomatic or asymptomatic GAS infection | Two-tailed Fisher’s exact test | 26 pairs concordant uninfected, 6 concordant infected, 5 pairs discordant |
| Bass et al | March 2010–October 2010 | 34-bed hematology–oncology ward in 427-bed tertiary care teaching hospital, Melbourne, Australia | Quasi-experimental | All pts w/neg VRE rectal swab upon admission and no known history of VRE | 439 pts | Incident VRE colonization detected by rectal surveillance culture | Roommate w/VRE infection or colonization | Cox proportional hazard adjusted for prior bed occupant status and study intervention phase | HR: 18.8 (5.4–66.2) |
| Bruce et al | August 1994–October 1996 | Special Immunity Service ward for HIV-pos pts, Grady Memorial Hospital | Retrospective cohort | Exposed: all roommates of pts w/ | 74 pts (37 exposed, 37 unexposed) | Incident cryptosporidiosis | Roommate w/cryptosporidiosis | Unadjusted RR | RR undefined (one case in unexposed roommates, zero cases in exposed roommates) |
| Chang and Nelson | March 1987–August 1987 | 305-bed community hospital, Baltimore, MD | Retrospective cohort | All pts w/LOS >48 h | 2,859 pts | Incident | Roommate w/ | Unadjusted RR | RR: 2.7 (0.6–7.0) |
| Deutscher et al | October 2007–February 2008 | 57-bed long-term acute care hospital, New Mexico | Case–control | Cases: all pts w/incident GAS infection >48 h after admission; controls: randomly selected pts w/o GAS symptoms or cultures | 50 residents (11 cases, 39 controls) | Incident GAS infection >48 h after admission | Roommate w/GAS infection or colonization | Logistic regression adjusted for age, sex, BMI, death, admission to special care unit, LOS >4 weeks, admission from home, | OR: 15.3 (2.5–110.9) |
| Drinka et al | 1993–2000 | Wisconsin Veterans Home, a 635-bed skilled nursing facility | Retrospective cohort | All residents | 3,294 resident- seasons | Culture confirmed influenza A infection | Roommate w/pos influenza A culture | Unadjusted RR comparing exposed to pos roommate versus single room | RR: 3.1 (1.6–5.8) |
| Drinka et al | 1992–1993 influenza season | Wisconsin Veterans Home, a 635-bed skilled nursing facility | Retrospective cohort | All residents | 489 resident- seasons | Culture confirmed influenza B infection | Roommate w/pos influenza B culture | Unadjusted RR comparing exposed to pos roommate versus single room | RR: 2.6 (1.2–5.6) |
| Forns et al | August 2000–October 2002 | Three-ward liver unit in tertiary care center | Prospective cohort | All pts w/neg anti-HCV screen upon ward admission | 1,301 pts | Incident HCV infection assessed 6 months postdischarge | Roommate w/HCV infection | Unadjusted OR | OR: 12.0 (1.4–103.0) |
| Furuno et al | March 2005–September 2008 | 120-bed Baltimore Rehabilitation and Extended Care Center, 150-bed Perry Point VA Medical Center, 180-bed University Specialty Hospital, Maryland | Prospective cohort | All residents w/o history of MRSA colonization, ≥1 neg MRSA screen from anterior nares or skin breakdown at enrollment, LOS >7 days, and ≥1 follow-up culture | Residential care: 286; rehabilitation care:157 residents | Incident MRSA colonization in anterior nares or site of skin breakdown | Roommate w/MRSA colonization | Residential care: Cox proportional hazard adjusted for antibiotic therapy and bedbound status; rehabilitation care: Cox proportional hazard HR adjusted for bedbound status and limited mobility status | Residential care HR: 1.4 (0.5–3.9); rehabilitation care HR: 0.5 (0.1–2.2) |
| Greene et al | January 2001–December 2001 | 120-bed long-term care facility, Georgia | Retrospective cohort | All residents | 125 residents | GAS infection or colonization | Roommate w/GAS colonization or infection | Unadjusted and Mantel–Haenszel RR (variables included in multivariable not described) | Adjusted RR: 2.0 (1.1–5.1); unadjusted RR: 2.1 (1.1–4.0) |
| Pegues et al | August 1989–September 1989 | St Christopher’s Hospital for Children, a 350-bed pediatric referral center, Philadelphia, PA | Case–control | Cases: CF pts w/initial isolation of | 28 pts (14 cases, 14 controls) | Pos | Roommate w/pos | Unadjusted OR | OR: 12.5 (0.6–607.0) |
| Shorman and Al-Tawfiq | February 2006–March 2010 | Tertiary care referral hospital, Damman, Saudi Arabia | Case–control | Cases: pts w/pos surveillance or clinical VRE cultures; controls: randomly selected pts w/neg clinical or surveillance VRE cultures | 90 pts (30 cases, 60 controls) | VRE colonization or infection | Roommate with VRE infection or colonization | Unadjusted OR | OR: 0.04 (0.004–0.4) |
Abbreviations: BMI, body mass index; CF, cystic fibrosis; CHF, congestive heart failure; GAS, group A streptococcus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HR, hazard ratio; LOS, length of stay; MRSA, methicillin-resistant Staphylococcus aureus; neg, negative; OR, odds ratio; pos, positive; P. cepacia, Pseudomonas cepacia; pts, patients; PVD, peripheral vascular disease; RR, relative risk; VRE, vancomycin-resistant enterococci; w/, with; w/o, without.
Figure 2Findings of studies investigating the association between health care-associated infection or colonization and exposure to infected or colonized roommates.
Notes: Studies reporting significant positive associations are represented in black circles and those reporting significant negative associations are represented in white circles. Studies that did not find statistically significant associations are represented in gray circles. Circles display study authors, setting, investigation of endemic versus epidemic pathogen, and quality score.
Summary and quality assessment of studies reporting associations between health care-associated infection and exposure to infected or colonized prior room occupants
| Author, quality score | Study period | Setting | Design | Subjects | N | Outcome | Exposure | Analysis | Results |
|---|---|---|---|---|---|---|---|---|---|
| Ajao et al | September 2001–June 2009 | Medical and surgical ICUs in University of Maryland Medical Center | Retrospective cohort | All pts ≥18 years w/o ESBL at hospital admission, neg ESBL screen at ICU admission, and ICU stay ≥48 h | 9,371 admissions (7,651 unique pts) | Acquisition of ESBL- producing pathogen during ICU stay detected by clinical or surveillance culture | Immediate prior room occupant w/pos clinical or surveillance ESBL culture | Logistic regression adjusted for colonization pressure, renal disease, anti-MRSA, and anti-pseudomonal beta- lactam therapies | Unadjusted OR: 1.9 (1.3–2.7); adjusted OR: 1.4 (0.9–2.1) |
| Bass et al | March 2010–October 2010 | 34-bed hematology–oncology ward in 427-bed tertiary care teaching hospital, Melbourne, Australia | Quasi-experimental | All pts w/neg VRE rectal swab upon admission and no known history of VRE | 439 pts | Incident VRE colonization detected by rectal surveillance culture | Prior bed occupant w/VRE colonization or infection | Cox proportional hazard adjusted for roommate status and study intervention phase | HR: 0.4 (0.1–1.2) |
| Chang and Nelson | March 1987–August 1987 | 305-bed community hospital, Baltimore, MD | Retrospective cohort | All pts w/LOS >48 h | 2,859 pts | Incident | Prior room occupant with | Unadjusted RR | RR: 1.2 (0.3–3.4) |
| Datta et al | September 2003–April 2005 and September 2006–April 2008 | ICUs in 750-bed academic medical center | Quasi-experimental | All pts w/neg MRSA and/or VRE screening culture prior to ICU admission | MRSA: 16,345 pts (7,629 baseline, 8,716 intervention); VRE: 16,630 pts (7,806 baseline, 8,824 intervention) | Incident MRSA or VRE acquisition | Prior room occupant | GLM adjusted for age, sex, pre-ICU LOS, prior occupant LOS, duration of room vacancy, clustering by ward, diabetes, end-stage renal and liver diseases, malignancies, immunocompromised status | MRSA: baseline OR: 1.4 ( |
| Drees et al | February 2002–March 2003 | Medical and surgical ICUs, Tufts-New England Medical Center, Boston, MA | Prospective interventional crossover | All pts in ICU ≥48 h w/neg VRE screens within first 48 h of ICU admission and no known history of VRE | 638 pts | Acquisition of VRE during ICU stay detected by surveillance culture | Prior room occupant (immediate and within previous 2 weeks) | HR adjusting for average colonization pressure and mean antibiotics per day | Immediate prior occupant HR: 3.8 (2.0–7.4); prior occupant within 2 weeks HR: 2.7 (1.4–5.3) |
| Huang et al | September 2003–April 2005 | Eight adult ICUs, Brigham and Women’s Hospital, Boston, MA | Retrospective cohort | All pts w/o pos MRSA or VRE surveillance cultures within 2 days of ICU admission | MRSA: 7,629 pts; VRE: 7,806 pts | Acquisition of MRSA or VRE | Prior room occupant with MRSA or VRE colonization or infection | GLM accounting for clustering within ICUs and controlling for age, sex, LOS before ICU admission, prior occupant LOS, duration of room vacancy before occupancy, diabetes, end-stage renal and liver diseases, noncancer immunocompromised state, and malignancies | MRSA OR:1.4 (1.0–1.8); VRE OR: 1.4 (1.0–1.9) |
| Nseir et al | December 2006–December 2007 | 30-bed medical/surgical ICU | Prospective cohort | All pts in ICU >48 h w/neg MDR GNB screen at admission | 511 pts | Acquisition of | Prior room occupant w/pos MDR GNB screening or diagnostic culture | Logistic regression: MDR | MDR |
| Shaughnessy et al | January 2005–June 2006 | 20-bed ICU in 809-bed tertiary care hospital | Retrospective cohort | All pts w/o | 1,770 pts | Incident | Immediate prior room occupant w/history of pos | Adjusted HR controlling for age, APACHE II, proton pump inhibitor, and exposure to antibiotics | HR: 2.4 (1.2–4.5) |
Abbreviations: APACHE II, acute physiology and chronic health evaluation II; ESBL, extended-spectrum beta-lactamase–producing organism; GLM, generalized linear mixed model; GNB, Gram-negative bacteria; HR, hazard ratio; ICU, intensive care unit; LOD, logistic organ dysfunction score; LOS, length of stay; MDR, multidrug resistant; MRSA, methicillin-resistant Staphylococcus aureus; neg, negative; OR, odds ratio; pts, patients; pos, positive; RR, relative risk; SAPS II, simplified acute physiology score II; VRE, vancomycin-resistant enterococci; w/, with; w/o, without.
Figure 3Findings of studies investigating the association between health care-associated infection or colonization and exposure to infected or colonized prior room occupants.
Notes: Studies reporting significant positive associations are represented in black circles. Studies that did not find statistically significant associations are represented in gray circles. No studies reported a significant negative association. Circles display study authors, setting, investigation of endemic versus epidemic pathogen, and quality score.